Drug Details
General Information of the Drug (ID: DR8104) | ||||
---|---|---|---|---|
Name |
Cis-diamminedichloroplatinum
|
|||
Synonyms |
cis-Platin; cis-DDP; Cisplatine; Cisplatino; Cisplatinum; Lederplatin; Briplatin; Cismaplat; Neoplatin; Platamine; Platinex; Randa; trans-platin; cis-Dichlorodiammineplatinum(II); Peyrone's salt; cis-Diamminedichloroplatinum; Peyrone's chloride; trans-Platinum(II) ammonium chloride; cis-[PtCl2(NH3)2]; trans-Dichlorodiammine platinum; trans-Platinumdiammine dichloride; CHEBI:27899; CHEBI:35852; TRANS-DIAMMINEDICHLOROPLATINUM; trans-Platinum(II) diamminedichloride; trans-DDP, 8; Cisplatin, 1; Epitope ID:194799; Epitope ID:194800; BDBM92386; cis-diamminedichloridoplatinum(II); (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloroplatinum; trans-diamminedichloridoplatinum(II); (SP-4-1)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloridoplatinum; AKOS025117566; DB00515; EU-0100918
Click to Show/Hide
|
|||
Molecular Type |
Small molecule
|
|||
Disease | Ovarian cancer [ICD-11: 2C73] | Approved | [1] | |
Structure |
![]() |
Click to Download Mol2D MOL |
||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | ||||
Formula |
Cl2H6N2Pt+2
|
|||
PubChem CID | ||||
Canonical SMILES |
N.N.Cl[Pt+2]Cl
|
|||
InChI |
1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+4/p-2
|
|||
InChIKey |
BSJGASKRWFKGMV-UHFFFAOYSA-L
|
|||
CAS Number |
CAS 15663-27-1
|
|||
ChEBI ID | ||||
DrugBank ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Natural Product(s) Able to Enhance the Efficacy of This Drug | ||||||
Antineoplaston A10 | Homo sapiens | Click to Show/Hide the Molecular Data of This NP | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
In-vitro Model | KIM-1 | CVCL_7969 | Adult hepatocellular carcinoma | Homo sapiens | ||
In-vivo Model | The KIM-1 cell suspension was implanted subcutaneously in BALB/c athymic mice. | |||||
Experimental
Result(s) |
The inhibitory effect of the combination of antineoplaston A-10 injection with a small dose of cis-diamminedichloroplatinum on cell and tumor growth of human hepatocellular carcinoma. | |||||
Quercetin | Averrhoa carambola | Click to Show/Hide the Molecular Data of This NP | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [3] | |||||
Detail(s) |
Combination Info
![]() |
|||||
In-vitro Model | LXFL 529L | CVCL_D085 | Lung non-small cell carcinoma | Homo sapiens | ||
Experimental
Result(s) |
Quercetin enhances the antiproliferative activity of cis-diamminedichloroplatinum (II) in lung cancer cells. | |||||
β. A List of Natural Product(s) Able to Decrease the Adverse Effect of This Drug | ||||||
Selenium | Soil | Click to Show/Hide the Molecular Data of This NP | ||||
Decreasing Adverse Drug Reaction | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [4] | |||||
Detail(s) |
Combination Info
![]() |
|||||
In-vitro Model | MC B6-1 cells dissociated from solid tumor | Fibrosarcoma | Rattus norvegicus | |||
In-vivo Model | The MC B6-1 fibrosarcoma was originally induced by s.c.injection of 2 mg of methylcholanthrene in a female C57BL/6 mouse and serially transplanted in syngeneic mice. | |||||
Experimental
Result(s) |
The addition of selenium decreases the nephrotoxicity of cis-DDP. |
